Related Experiment Videos
An evidence-based clinical pathway for bronchiolitis safely reduces antibiotic overuse
Stephen D Wilson1, Barbara B Dahl, Robert D Wells
1Department of Pediatrics, University of California, San Francisco, 94143, USA. swilson@itsa.ucsf.edu
Summary
A new clinical pathway significantly reduced antibiotic overuse in hospitalized children with bronchiolitis. This approach improved care quality, lowered costs, and shortened hospital stays without negative impacts.
Area of Science:
- Pediatrics
- Infectious Diseases
- Health Services Research
Background:
- Antibiotic overuse is a persistent issue in managing bronchiolitis.
- Physician practice patterns have been slow to adapt to evidence-based guidelines.
Purpose of the Study:
- To evaluate the effectiveness of a clinical pathway in reducing antibiotic overuse for inpatient bronchiolitis management.
- To assess the impact of the pathway on quality of care, cost, and length of stay.
Main Methods:
- Retrospective chart review of 181 children admitted for bronchiolitis.
- Comparison of antibiotic use between patients managed with a clinical pathway and a matched non-pathway group.
Main Results:
- Antibiotic use decreased from 27% in the non-pathway group to 9% in the pathway group.
- No adverse effects on other quality measures, such as unplanned returns for care.
- Significant reductions in cost and length of hospital stay for pathway patients.
Conclusions:
- Clinical pathways are effective in modifying physician practice regarding antibiotic use in bronchiolitis.
- Implementation of clinical pathways can reduce unnecessary antibiotic prescriptions while maintaining or improving care quality.
- This strategy offers benefits in terms of cost-effectiveness and patient outcomes.